Shenzhen Haibin Pharmaceutical Co. Ltd
Shenzhen Haibin Pharmaceutical Co. Ltd., commonly referred to as Haibin Pharma, is a prominent player in the pharmaceutical industry, headquartered in Shenzhen, China. Established in 2001, the company has rapidly expanded its operations across major regions in Asia and beyond, focusing on the development and manufacturing of high-quality pharmaceutical products. Specialising in active pharmaceutical ingredients (APIs) and finished dosage forms, Haibin Pharma is recognised for its commitment to innovation and quality. The company’s core offerings include a diverse range of generic medications and specialty pharmaceuticals, which are distinguished by their efficacy and safety profiles. With a strong market position, Haibin Pharma has achieved significant milestones, including various certifications and partnerships that underscore its reputation for excellence in the pharmaceutical sector.
DitchCarbon Score
How does Shenzhen Haibin Pharmaceutical Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shenzhen Haibin Pharmaceutical Co. Ltd's score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shenzhen Haibin Pharmaceutical Co. Ltd's reported carbon emissions
Shenzhen Haibin Pharmaceutical Co. Ltd, headquartered in CN, currently does not have available carbon emissions data for recent years, nor does it specify any reduction targets or climate commitments. Without specific emissions figures or defined initiatives, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. As the sector increasingly focuses on sustainability, it is essential for companies like Shenzhen Haibin Pharmaceutical to establish clear climate strategies and measurable targets to align with global efforts in reducing greenhouse gas emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shenzhen Haibin Pharmaceutical Co. Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
